Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Uterine Neoplasms | 43 | 2023 | 1513 | 3.130 |
Why?
|
Leiomyoma | 27 | 2023 | 730 | 2.280 |
Why?
|
Leiomyosarcoma | 16 | 2023 | 477 | 1.710 |
Why?
|
Adenosarcoma | 3 | 2017 | 34 | 1.200 |
Why?
|
Smooth Muscle Tumor | 5 | 2023 | 67 | 0.900 |
Why?
|
Translocation, Genetic | 16 | 2023 | 1420 | 0.880 |
Why?
|
Leiomyomatosis | 6 | 2022 | 70 | 0.840 |
Why?
|
Endometrial Neoplasms | 9 | 2023 | 1353 | 0.750 |
Why?
|
Chromosome Aberrations | 11 | 2017 | 1813 | 0.720 |
Why?
|
Chromosomes, Human, Pair 8 | 4 | 2017 | 460 | 0.710 |
Why?
|
Neurotransmitter Agents | 2 | 2021 | 647 | 0.660 |
Why?
|
Placenta | 8 | 2024 | 1698 | 0.640 |
Why?
|
HMGA2 Protein | 7 | 2012 | 123 | 0.590 |
Why?
|
Mixed Tumor, Mullerian | 1 | 2017 | 56 | 0.580 |
Why?
|
Neoplasm Seeding | 2 | 2013 | 87 | 0.540 |
Why?
|
Nerve Tissue Proteins | 6 | 2021 | 4462 | 0.540 |
Why?
|
Chromosomes, Human, Pair 12 | 5 | 2004 | 462 | 0.520 |
Why?
|
Choriocarcinoma | 3 | 2017 | 126 | 0.480 |
Why?
|
Endometrial Stromal Tumors | 1 | 2013 | 44 | 0.440 |
Why?
|
Endometrium | 9 | 2023 | 424 | 0.440 |
Why?
|
Hydatidiform Mole | 3 | 2020 | 279 | 0.430 |
Why?
|
Uterine Cervical Dysplasia | 4 | 2018 | 387 | 0.420 |
Why?
|
Peritoneum | 1 | 2012 | 228 | 0.400 |
Why?
|
Chromosomes, Human, Pair 10 | 2 | 2004 | 287 | 0.390 |
Why?
|
Uterine Cervical Neoplasms | 8 | 2018 | 2020 | 0.380 |
Why?
|
Antigens, Differentiation | 1 | 2013 | 927 | 0.370 |
Why?
|
Uterus | 8 | 2024 | 711 | 0.360 |
Why?
|
Placenta Diseases | 2 | 2023 | 199 | 0.360 |
Why?
|
Myometrium | 6 | 2012 | 181 | 0.350 |
Why?
|
In Situ Hybridization, Fluorescence | 19 | 2018 | 2649 | 0.350 |
Why?
|
Stromal Cells | 3 | 2015 | 1355 | 0.340 |
Why?
|
Fallopian Tubes | 1 | 2010 | 182 | 0.340 |
Why?
|
Li-Fraumeni Syndrome | 1 | 2010 | 114 | 0.330 |
Why?
|
Pelvic Neoplasms | 2 | 2022 | 254 | 0.330 |
Why?
|
SNARE Proteins | 3 | 2017 | 88 | 0.320 |
Why?
|
DNA Copy Number Variations | 3 | 2023 | 1941 | 0.320 |
Why?
|
Kallmann Syndrome | 3 | 2023 | 140 | 0.310 |
Why?
|
Synaptic Vesicles | 2 | 2021 | 191 | 0.310 |
Why?
|
Immunohistochemistry | 19 | 2022 | 11366 | 0.290 |
Why?
|
Chromosome Breakage | 7 | 2012 | 173 | 0.270 |
Why?
|
Karyotyping | 11 | 2018 | 1243 | 0.270 |
Why?
|
Pregnancy Complications, Infectious | 3 | 2022 | 2026 | 0.260 |
Why?
|
Hysterectomy | 8 | 2024 | 927 | 0.260 |
Why?
|
Genetic Predisposition to Disease | 9 | 2019 | 17446 | 0.250 |
Why?
|
Cell Membrane | 4 | 2021 | 3748 | 0.240 |
Why?
|
Female | 91 | 2024 | 380194 | 0.240 |
Why?
|
Chromosomes, Human, Pair 17 | 2 | 2007 | 437 | 0.240 |
Why?
|
Peritoneal Neoplasms | 3 | 2013 | 665 | 0.240 |
Why?
|
Loss of Heterozygosity | 3 | 2010 | 684 | 0.230 |
Why?
|
Trophoblasts | 3 | 2023 | 215 | 0.230 |
Why?
|
Agrin | 1 | 2023 | 68 | 0.230 |
Why?
|
Acetyltransferases | 1 | 2004 | 234 | 0.220 |
Why?
|
Neurons | 3 | 2021 | 9338 | 0.220 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2018 | 1581 | 0.220 |
Why?
|
DNA Helicases | 1 | 2008 | 859 | 0.210 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2017 | 2948 | 0.210 |
Why?
|
Receptors, Cholinergic | 1 | 2023 | 238 | 0.210 |
Why?
|
Endometrial Hyperplasia | 1 | 2023 | 97 | 0.210 |
Why?
|
Papillomaviridae | 4 | 2003 | 1119 | 0.210 |
Why?
|
Craniofacial Abnormalities | 3 | 2012 | 315 | 0.210 |
Why?
|
Placenta Previa | 1 | 2024 | 117 | 0.210 |
Why?
|
Chromosomes, Human, Pair 3 | 3 | 2007 | 323 | 0.210 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 4 | 2018 | 705 | 0.210 |
Why?
|
Cyclin E | 2 | 2001 | 172 | 0.200 |
Why?
|
Papillomavirus Infections | 4 | 2018 | 1587 | 0.200 |
Why?
|
Computational Biology | 2 | 2013 | 3521 | 0.200 |
Why?
|
Ovarian Neoplasms | 5 | 2021 | 4838 | 0.200 |
Why?
|
Scoliosis | 1 | 2008 | 725 | 0.200 |
Why?
|
Gene Expression Profiling | 7 | 2019 | 9438 | 0.190 |
Why?
|
Chromosome Deletion | 5 | 2012 | 1401 | 0.190 |
Why?
|
Dermoid Cyst | 1 | 2021 | 93 | 0.190 |
Why?
|
Mediator Complex | 2 | 2018 | 109 | 0.190 |
Why?
|
Myxoma | 1 | 2001 | 130 | 0.190 |
Why?
|
Dosage Compensation, Genetic | 2 | 2002 | 211 | 0.180 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2019 | 2942 | 0.180 |
Why?
|
Syntaxin 1 | 1 | 2020 | 30 | 0.180 |
Why?
|
Sarcoma, Endometrial Stromal | 1 | 2001 | 91 | 0.180 |
Why?
|
Placenta Accreta | 1 | 2024 | 225 | 0.180 |
Why?
|
Phosphoproteins | 4 | 2002 | 2440 | 0.180 |
Why?
|
Vaginal Smears | 1 | 2003 | 511 | 0.180 |
Why?
|
Humans | 106 | 2024 | 744343 | 0.180 |
Why?
|
Vulvar Neoplasms | 2 | 2003 | 272 | 0.180 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2001 | 249 | 0.180 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2009 | 8428 | 0.170 |
Why?
|
High Mobility Group Proteins | 4 | 2002 | 187 | 0.170 |
Why?
|
Trans-Activators | 4 | 2002 | 2924 | 0.170 |
Why?
|
Adenomyoma | 1 | 2018 | 10 | 0.170 |
Why?
|
Cytoplasmic Vesicles | 1 | 2019 | 74 | 0.170 |
Why?
|
Candida albicans | 1 | 2022 | 394 | 0.170 |
Why?
|
Teratoma | 1 | 2021 | 395 | 0.170 |
Why?
|
Ki-67 Antigen | 4 | 2003 | 644 | 0.160 |
Why?
|
Serine Proteases | 1 | 2018 | 52 | 0.160 |
Why?
|
Pregnancy Trimester, Third | 1 | 2021 | 571 | 0.160 |
Why?
|
Adult | 43 | 2023 | 214055 | 0.160 |
Why?
|
Stillbirth | 1 | 2021 | 346 | 0.160 |
Why?
|
Polyps | 2 | 2015 | 189 | 0.160 |
Why?
|
Pregnancy | 17 | 2024 | 29144 | 0.160 |
Why?
|
Intracellular Membranes | 1 | 2019 | 390 | 0.160 |
Why?
|
Cell Differentiation | 4 | 2013 | 11483 | 0.160 |
Why?
|
Munc18 Proteins | 1 | 2017 | 29 | 0.150 |
Why?
|
Chromosomes, Human, Pair 7 | 3 | 2009 | 322 | 0.150 |
Why?
|
Carcinoma | 3 | 2019 | 2375 | 0.150 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2008 | 3920 | 0.150 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2023 | 489 | 0.150 |
Why?
|
Genome-Wide Association Study | 3 | 2018 | 12261 | 0.150 |
Why?
|
Fallopian Tube Neoplasms | 2 | 2010 | 324 | 0.150 |
Why?
|
R-SNARE Proteins | 1 | 2017 | 74 | 0.150 |
Why?
|
RNA-Binding Protein EWS | 1 | 2018 | 216 | 0.150 |
Why?
|
Lanthanoid Series Elements | 1 | 2016 | 16 | 0.150 |
Why?
|
Papillomavirus Vaccines | 1 | 2003 | 491 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2020 | 1434 | 0.140 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 2 | 2016 | 507 | 0.140 |
Why?
|
Abnormalities, Multiple | 4 | 2007 | 1416 | 0.140 |
Why?
|
Fibrosarcoma | 1 | 2018 | 348 | 0.140 |
Why?
|
Chromosomes, Human, Pair 2 | 3 | 2008 | 326 | 0.140 |
Why?
|
DNA-Binding Proteins | 6 | 2009 | 9648 | 0.140 |
Why?
|
Cystadenocarcinoma, Serous | 2 | 2010 | 450 | 0.140 |
Why?
|
Liposarcoma | 1 | 2019 | 333 | 0.140 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2018 | 514 | 0.140 |
Why?
|
Vascular Neoplasms | 2 | 2016 | 175 | 0.130 |
Why?
|
Gene Fusion | 1 | 2018 | 371 | 0.130 |
Why?
|
Membrane Fusion | 1 | 2017 | 273 | 0.130 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2002 | 1504 | 0.130 |
Why?
|
Trophoblastic Neoplasms | 1 | 2015 | 87 | 0.130 |
Why?
|
Mutation | 8 | 2021 | 29786 | 0.130 |
Why?
|
Endometriosis | 4 | 2004 | 839 | 0.120 |
Why?
|
Chromosomes, Human, Pair 1 | 3 | 2007 | 658 | 0.120 |
Why?
|
GATA3 Transcription Factor | 1 | 2015 | 157 | 0.120 |
Why?
|
Membrane Proteins | 5 | 2023 | 7880 | 0.120 |
Why?
|
Neoplasms, Muscle Tissue | 1 | 2015 | 83 | 0.120 |
Why?
|
Receptors, Estrogen | 3 | 2023 | 2187 | 0.120 |
Why?
|
Genital Neoplasms, Female | 2 | 2014 | 523 | 0.120 |
Why?
|
Germ-Line Mutation | 2 | 2013 | 1788 | 0.120 |
Why?
|
Pre-Eclampsia | 1 | 2023 | 1200 | 0.120 |
Why?
|
Chromosome Mapping | 8 | 2008 | 4740 | 0.120 |
Why?
|
Chromosomes, Human, Pair 14 | 4 | 2003 | 299 | 0.110 |
Why?
|
Immunophenotyping | 4 | 2010 | 1880 | 0.110 |
Why?
|
Vascular Diseases | 1 | 2002 | 1161 | 0.110 |
Why?
|
Chromosome Banding | 2 | 2004 | 278 | 0.110 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 1 | 2014 | 75 | 0.110 |
Why?
|
p21-Activated Kinases | 1 | 2013 | 128 | 0.110 |
Why?
|
Rats | 6 | 2020 | 24260 | 0.110 |
Why?
|
Middle Aged | 30 | 2022 | 213383 | 0.110 |
Why?
|
Adenoma | 1 | 2023 | 2174 | 0.110 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2018 | 770 | 0.110 |
Why?
|
Necrosis | 3 | 2022 | 1643 | 0.100 |
Why?
|
Precancerous Conditions | 1 | 1998 | 975 | 0.100 |
Why?
|
Predictive Value of Tests | 6 | 2018 | 15076 | 0.100 |
Why?
|
Databases, Protein | 1 | 2013 | 383 | 0.100 |
Why?
|
Focal Adhesions | 1 | 2011 | 121 | 0.100 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2021 | 2915 | 0.100 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2012 | 417 | 0.100 |
Why?
|
Genomics | 2 | 2019 | 5720 | 0.100 |
Why?
|
Ultrasonic Therapy | 2 | 2003 | 235 | 0.100 |
Why?
|
Adenocarcinoma, Clear Cell | 1 | 2012 | 221 | 0.090 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2018 | 9239 | 0.090 |
Why?
|
Connexin 43 | 1 | 2011 | 207 | 0.090 |
Why?
|
Neoplasm Proteins | 2 | 2010 | 3703 | 0.090 |
Why?
|
Chickens | 1 | 2012 | 865 | 0.090 |
Why?
|
PAX2 Transcription Factor | 1 | 2010 | 80 | 0.090 |
Why?
|
Antibodies | 2 | 2018 | 2460 | 0.090 |
Why?
|
Comparative Genomic Hybridization | 3 | 2023 | 496 | 0.090 |
Why?
|
Genes, BRCA2 | 1 | 2013 | 618 | 0.090 |
Why?
|
Multiprotein Complexes | 1 | 2016 | 1119 | 0.090 |
Why?
|
Gap Junctions | 1 | 2011 | 233 | 0.090 |
Why?
|
Lipoma | 2 | 2004 | 334 | 0.090 |
Why?
|
Genes, BRCA1 | 1 | 2013 | 781 | 0.090 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2017 | 3760 | 0.090 |
Why?
|
Disease Models, Animal | 4 | 2012 | 18029 | 0.090 |
Why?
|
Chromosome Disorders | 1 | 2012 | 514 | 0.090 |
Why?
|
Tumor Virus Infections | 3 | 2003 | 452 | 0.080 |
Why?
|
Prognosis | 7 | 2022 | 29063 | 0.080 |
Why?
|
Receptors, Fibroblast Growth Factor | 2 | 2001 | 185 | 0.080 |
Why?
|
Chromosomes, Human, Pair 6 | 2 | 1999 | 380 | 0.080 |
Why?
|
Gene Rearrangement | 3 | 2007 | 1179 | 0.080 |
Why?
|
Hirsutism | 1 | 2008 | 69 | 0.080 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 1 | 2008 | 73 | 0.080 |
Why?
|
Genetic Heterogeneity | 1 | 2012 | 733 | 0.080 |
Why?
|
Diagnosis, Differential | 7 | 2017 | 12959 | 0.080 |
Why?
|
Cytogenetic Analysis | 4 | 2016 | 295 | 0.080 |
Why?
|
Animals | 21 | 2021 | 168757 | 0.080 |
Why?
|
DNA Primers | 3 | 2008 | 2892 | 0.080 |
Why?
|
DNA Mutational Analysis | 4 | 2010 | 4186 | 0.080 |
Why?
|
Histone Deacetylases | 1 | 2012 | 728 | 0.080 |
Why?
|
Carcinoma, Renal Cell | 1 | 2022 | 3143 | 0.080 |
Why?
|
Gingival Hyperplasia | 1 | 2007 | 17 | 0.080 |
Why?
|
NFI Transcription Factors | 1 | 2007 | 44 | 0.070 |
Why?
|
Aged | 17 | 2019 | 163280 | 0.070 |
Why?
|
Mice | 13 | 2021 | 81183 | 0.070 |
Why?
|
Mass Screening | 1 | 2003 | 5255 | 0.070 |
Why?
|
Uterine Hemorrhage | 3 | 2016 | 255 | 0.070 |
Why?
|
Cluster Analysis | 4 | 2012 | 2715 | 0.070 |
Why?
|
Genes, p53 | 1 | 2010 | 755 | 0.070 |
Why?
|
Protein Kinases | 1 | 2014 | 1640 | 0.070 |
Why?
|
Diacylglycerol Kinase | 1 | 2007 | 48 | 0.070 |
Why?
|
Haploidy | 1 | 2007 | 136 | 0.070 |
Why?
|
Mosaicism | 2 | 2009 | 441 | 0.070 |
Why?
|
Hypertrichosis | 1 | 2007 | 25 | 0.070 |
Why?
|
Receptor Protein-Tyrosine Kinases | 3 | 2023 | 1660 | 0.070 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2012 | 615 | 0.070 |
Why?
|
Human Development | 1 | 2008 | 124 | 0.070 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2008 | 373 | 0.070 |
Why?
|
Cells, Cultured | 2 | 2021 | 19229 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 5 | 2004 | 2849 | 0.070 |
Why?
|
Chromosomes, Human, X | 1 | 2008 | 296 | 0.070 |
Why?
|
Aged, 80 and over | 6 | 2018 | 57776 | 0.070 |
Why?
|
Disease Progression | 2 | 2020 | 13284 | 0.070 |
Why?
|
Chromosomes, Human, Y | 1 | 2007 | 148 | 0.070 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2005 | 250 | 0.070 |
Why?
|
Decidua | 1 | 2006 | 86 | 0.070 |
Why?
|
Infarction | 2 | 2023 | 244 | 0.070 |
Why?
|
Kidney Neoplasms | 1 | 2022 | 4262 | 0.070 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2008 | 255 | 0.070 |
Why?
|
Microsatellite Repeats | 2 | 1999 | 802 | 0.070 |
Why?
|
Germ Cells | 2 | 2018 | 631 | 0.070 |
Why?
|
Mitotic Index | 2 | 2016 | 172 | 0.070 |
Why?
|
Congenital Abnormalities | 2 | 2008 | 707 | 0.060 |
Why?
|
Nervous System Malformations | 1 | 2007 | 247 | 0.060 |
Why?
|
Pregnancy Trimester, Second | 1 | 2008 | 732 | 0.060 |
Why?
|
Cataract | 1 | 2011 | 834 | 0.060 |
Why?
|
DNA, Neoplasm | 3 | 2002 | 1758 | 0.060 |
Why?
|
Cell Adhesion Molecules | 1 | 2011 | 1602 | 0.060 |
Why?
|
Fibronectins | 1 | 1988 | 726 | 0.060 |
Why?
|
Mice, Mutant Strains | 1 | 2008 | 1866 | 0.060 |
Why?
|
Genes, Neoplasm | 2 | 2004 | 376 | 0.060 |
Why?
|
Embryonic and Fetal Development | 2 | 2002 | 438 | 0.060 |
Why?
|
Biopsy | 4 | 2019 | 6756 | 0.060 |
Why?
|
Genes, Tumor Suppressor | 4 | 2002 | 1097 | 0.060 |
Why?
|
MicroRNAs | 1 | 2020 | 3752 | 0.060 |
Why?
|
Keratin-14 | 2 | 2001 | 57 | 0.060 |
Why?
|
Autistic Disorder | 3 | 2012 | 1185 | 0.060 |
Why?
|
Genetic Markers | 2 | 2020 | 2634 | 0.060 |
Why?
|
Urogenital Abnormalities | 1 | 2007 | 261 | 0.060 |
Why?
|
Receptors, Immunologic | 2 | 2007 | 1423 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2001 | 4034 | 0.060 |
Why?
|
Cell Line | 5 | 2011 | 15997 | 0.060 |
Why?
|
Calcium Channels | 1 | 2007 | 622 | 0.060 |
Why?
|
Skin Neoplasms | 1 | 2023 | 5686 | 0.060 |
Why?
|
Carcinoma, Adenosquamous | 2 | 2001 | 68 | 0.060 |
Why?
|
Fetal Growth Retardation | 2 | 2006 | 570 | 0.060 |
Why?
|
Urinary Tract | 1 | 2007 | 309 | 0.060 |
Why?
|
PTEN Phosphohydrolase | 3 | 2023 | 1142 | 0.060 |
Why?
|
Vesico-Ureteral Reflux | 1 | 2007 | 427 | 0.060 |
Why?
|
LDL-Receptor Related Proteins | 1 | 2023 | 115 | 0.060 |
Why?
|
Fumarate Hydratase | 1 | 2022 | 47 | 0.050 |
Why?
|
Sensitivity and Specificity | 4 | 2018 | 14722 | 0.050 |
Why?
|
Urogenital System | 1 | 2002 | 86 | 0.050 |
Why?
|
Rad51 Recombinase | 1 | 2003 | 189 | 0.050 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2004 | 473 | 0.050 |
Why?
|
Histone Acetyltransferases | 1 | 2004 | 336 | 0.050 |
Why?
|
Keratins | 2 | 2001 | 515 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Neuropeptides | 1 | 2008 | 942 | 0.050 |
Why?
|
Fibroblast Growth Factor 2 | 2 | 2001 | 599 | 0.050 |
Why?
|
Disease-Free Survival | 3 | 2019 | 6895 | 0.050 |
Why?
|
Genome, Human | 2 | 2008 | 4420 | 0.050 |
Why?
|
Adolescent | 5 | 2023 | 85781 | 0.050 |
Why?
|
Gene Expression Regulation, Developmental | 3 | 2008 | 3617 | 0.050 |
Why?
|
RNA, Neoplasm | 1 | 2004 | 769 | 0.050 |
Why?
|
Desmin | 1 | 2001 | 130 | 0.050 |
Why?
|
Biophysical Phenomena | 1 | 2021 | 327 | 0.050 |
Why?
|
Neuromuscular Junction | 1 | 2023 | 398 | 0.050 |
Why?
|
Base Sequence | 3 | 2008 | 12797 | 0.050 |
Why?
|
Adenocarcinoma | 4 | 2003 | 6364 | 0.050 |
Why?
|
Neoplasm Staging | 3 | 2022 | 11031 | 0.050 |
Why?
|
Sequence Analysis, DNA | 3 | 2012 | 4803 | 0.050 |
Why?
|
Cleft Lip | 1 | 2005 | 478 | 0.050 |
Why?
|
Phenotype | 4 | 2018 | 16365 | 0.050 |
Why?
|
Gynecology | 2 | 2019 | 513 | 0.050 |
Why?
|
Neprilysin | 1 | 2003 | 439 | 0.040 |
Why?
|
Observer Variation | 2 | 2019 | 2593 | 0.040 |
Why?
|
Alternative Splicing | 2 | 2003 | 1117 | 0.040 |
Why?
|
DNA Damage | 1 | 2010 | 2432 | 0.040 |
Why?
|
Cleft Palate | 1 | 2005 | 560 | 0.040 |
Why?
|
RNA Helicases | 1 | 2000 | 142 | 0.040 |
Why?
|
Retrospective Studies | 10 | 2024 | 77449 | 0.040 |
Why?
|
Glycoproteins | 1 | 2008 | 2263 | 0.040 |
Why?
|
Cerebellar Neoplasms | 1 | 2004 | 587 | 0.040 |
Why?
|
Adnexa Uteri | 1 | 2019 | 45 | 0.040 |
Why?
|
Developmental Disabilities | 1 | 2008 | 1456 | 0.040 |
Why?
|
Mice, Knockout | 4 | 2021 | 14557 | 0.040 |
Why?
|
Protein Conformation | 2 | 2020 | 4011 | 0.040 |
Why?
|
ras Proteins | 1 | 2004 | 1060 | 0.040 |
Why?
|
Fetal Death | 1 | 2021 | 448 | 0.040 |
Why?
|
Tumor Burden | 2 | 2016 | 1915 | 0.040 |
Why?
|
Molecular Dynamics Simulation | 1 | 2021 | 413 | 0.040 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2023 | 890 | 0.040 |
Why?
|
DNA, Viral | 3 | 2001 | 2225 | 0.040 |
Why?
|
Cohort Studies | 2 | 2022 | 40561 | 0.040 |
Why?
|
Ploidies | 1 | 2019 | 281 | 0.040 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 365 | 0.040 |
Why?
|
Young Adult | 4 | 2021 | 56430 | 0.040 |
Why?
|
Receptors, Progesterone | 1 | 2023 | 1097 | 0.040 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2002 | 903 | 0.040 |
Why?
|
Clone Cells | 1 | 2002 | 1692 | 0.040 |
Why?
|
Online Systems | 1 | 2019 | 184 | 0.040 |
Why?
|
Cell Nucleus | 2 | 2016 | 2969 | 0.040 |
Why?
|
Omentum | 1 | 2019 | 170 | 0.040 |
Why?
|
RNA, Messenger | 3 | 2003 | 13033 | 0.040 |
Why?
|
Early Diagnosis | 1 | 2003 | 1184 | 0.040 |
Why?
|
Cysteine | 1 | 2022 | 874 | 0.040 |
Why?
|
Cicatrix | 1 | 2024 | 764 | 0.040 |
Why?
|
Immunoenzyme Techniques | 1 | 2001 | 1799 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 2012 | 7722 | 0.040 |
Why?
|
Hypoxanthine Phosphoribosyltransferase | 1 | 1997 | 68 | 0.040 |
Why?
|
Veins | 1 | 2002 | 770 | 0.040 |
Why?
|
Calorimetry | 1 | 2017 | 126 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 53 | 0.040 |
Why?
|
Mucins | 1 | 2000 | 564 | 0.040 |
Why?
|
Risk Assessment | 3 | 2023 | 23338 | 0.040 |
Why?
|
RNA | 2 | 2004 | 2749 | 0.040 |
Why?
|
Biological Transport | 1 | 2021 | 2118 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 11524 | 0.040 |
Why?
|
Muscle, Smooth | 1 | 2001 | 934 | 0.040 |
Why?
|
Telomere | 1 | 2003 | 910 | 0.040 |
Why?
|
Cervix Uteri | 1 | 2001 | 590 | 0.040 |
Why?
|
Self Disclosure | 1 | 2018 | 251 | 0.040 |
Why?
|
Syndrome | 3 | 2007 | 3251 | 0.040 |
Why?
|
Atrophy | 1 | 2001 | 1583 | 0.030 |
Why?
|
Epithelium | 1 | 2001 | 1679 | 0.030 |
Why?
|
Sarcoma | 1 | 2007 | 1897 | 0.030 |
Why?
|
Epithelial Cells | 3 | 2002 | 3690 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2018 | 11124 | 0.030 |
Why?
|
Pathology, Molecular | 1 | 2019 | 326 | 0.030 |
Why?
|
Synaptic Transmission | 1 | 2021 | 1178 | 0.030 |
Why?
|
Fetus | 2 | 2000 | 1880 | 0.030 |
Why?
|
Isotope Labeling | 1 | 2016 | 406 | 0.030 |
Why?
|
Cesarean Section | 1 | 2024 | 1365 | 0.030 |
Why?
|
Aging | 2 | 2012 | 8664 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 2020 | 1072 | 0.030 |
Why?
|
Carcinoma in Situ | 1 | 2001 | 806 | 0.030 |
Why?
|
Freeze Fracturing | 2 | 2011 | 68 | 0.030 |
Why?
|
Signal Transduction | 3 | 2023 | 23403 | 0.030 |
Why?
|
Cerebellum | 1 | 2021 | 1488 | 0.030 |
Why?
|
Point Mutation | 1 | 2020 | 1623 | 0.030 |
Why?
|
Human Genome Project | 2 | 2008 | 193 | 0.030 |
Why?
|
Cell Communication | 1 | 2021 | 1621 | 0.030 |
Why?
|
Seizures | 1 | 2007 | 2859 | 0.030 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2021 | 1320 | 0.030 |
Why?
|
Blotting, Western | 2 | 2015 | 5179 | 0.030 |
Why?
|
X Chromosome | 1 | 1997 | 814 | 0.030 |
Why?
|
Oviducts | 1 | 2012 | 11 | 0.030 |
Why?
|
Wnt Proteins | 2 | 2007 | 721 | 0.030 |
Why?
|
Molecular Sequence Data | 5 | 2007 | 18111 | 0.030 |
Why?
|
Poultry Diseases | 1 | 2012 | 25 | 0.030 |
Why?
|
Decision Trees | 1 | 1995 | 506 | 0.030 |
Why?
|
Exostoses, Multiple Hereditary | 1 | 2012 | 29 | 0.030 |
Why?
|
Protein Structure, Tertiary | 2 | 2011 | 3846 | 0.030 |
Why?
|
Permeability | 1 | 2014 | 738 | 0.030 |
Why?
|
Cell Cycle | 1 | 2001 | 2967 | 0.030 |
Why?
|
Filipin | 1 | 2011 | 13 | 0.030 |
Why?
|
Spectrometry, Fluorescence | 1 | 2014 | 689 | 0.030 |
Why?
|
Polymerase Chain Reaction | 3 | 2009 | 6171 | 0.030 |
Why?
|
Premenopause | 3 | 2002 | 1033 | 0.030 |
Why?
|
Remission Induction | 1 | 2017 | 2386 | 0.030 |
Why?
|
New England | 1 | 2015 | 1022 | 0.030 |
Why?
|
Treatment Outcome | 6 | 2019 | 63114 | 0.030 |
Why?
|
In Situ Hybridization | 1 | 2016 | 1950 | 0.030 |
Why?
|
Phosphorylation | 2 | 2014 | 8436 | 0.030 |
Why?
|
RNA, Viral | 1 | 2020 | 2902 | 0.030 |
Why?
|
Hemorrhage | 1 | 2023 | 3461 | 0.020 |
Why?
|
Time Factors | 4 | 2016 | 40075 | 0.020 |
Why?
|
Cell Lineage | 1 | 2000 | 2504 | 0.020 |
Why?
|
Ovariectomy | 1 | 2013 | 661 | 0.020 |
Why?
|
Male | 13 | 2019 | 350118 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2016 | 970 | 0.020 |
Why?
|
Quinazolinones | 1 | 2012 | 221 | 0.020 |
Why?
|
Receptors, Androgen | 1 | 1997 | 1058 | 0.020 |
Why?
|
Peritoneal Cavity | 1 | 2010 | 148 | 0.020 |
Why?
|
Trisomy | 1 | 1992 | 266 | 0.020 |
Why?
|
Mitosis | 1 | 2016 | 1208 | 0.020 |
Why?
|
Membrane Lipids | 1 | 2011 | 248 | 0.020 |
Why?
|
Cause of Death | 1 | 2021 | 3584 | 0.020 |
Why?
|
Pandemics | 2 | 2021 | 8388 | 0.020 |
Why?
|
Heterozygote | 1 | 1997 | 2804 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2007 | 4751 | 0.020 |
Why?
|
Haploinsufficiency | 1 | 2012 | 328 | 0.020 |
Why?
|
Sodium Channels | 1 | 2012 | 349 | 0.020 |
Why?
|
Infant, Newborn | 3 | 2021 | 25625 | 0.020 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 1992 | 535 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2008 | 21827 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2023 | 5021 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3278 | 0.020 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2011 | 964 | 0.020 |
Why?
|
Amino Acid Sequence | 3 | 2007 | 13815 | 0.020 |
Why?
|
Tumor Cells, Cultured | 2 | 2012 | 6314 | 0.020 |
Why?
|
Receptors, Fibronectin | 1 | 1988 | 39 | 0.020 |
Why?
|
Hippocampus | 1 | 2021 | 3675 | 0.020 |
Why?
|
Risk Factors | 4 | 2015 | 72290 | 0.020 |
Why?
|
Leiomyoma, Epithelioid | 1 | 2008 | 3 | 0.020 |
Why?
|
Isoenzymes | 1 | 2013 | 1726 | 0.020 |
Why?
|
Nervous System | 1 | 2012 | 554 | 0.020 |
Why?
|
Pathology, Clinical | 1 | 2012 | 368 | 0.020 |
Why?
|
Prevalence | 2 | 2018 | 15226 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2019 | 4851 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6538 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2011 | 1723 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2019 | 2728 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3597 | 0.020 |
Why?
|
Mutation, Missense | 2 | 2008 | 2564 | 0.020 |
Why?
|
Menstrual Cycle | 2 | 2002 | 551 | 0.020 |
Why?
|
Tumor Suppressor Protein p14ARF | 1 | 2007 | 90 | 0.020 |
Why?
|
Limb Deformities, Congenital | 2 | 2003 | 136 | 0.020 |
Why?
|
Gene Expression | 1 | 2001 | 7799 | 0.020 |
Why?
|
Peptide Fragments | 2 | 2011 | 5097 | 0.020 |
Why?
|
DNA, Complementary | 2 | 2003 | 2050 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2011 | 1100 | 0.020 |
Why?
|
Intercellular Junctions | 1 | 1987 | 203 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2012 | 1375 | 0.020 |
Why?
|
Disulfides | 1 | 1988 | 457 | 0.020 |
Why?
|
Transcription Factors | 3 | 2001 | 12208 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2011 | 1791 | 0.020 |
Why?
|
Protein Kinase C | 1 | 2011 | 1227 | 0.020 |
Why?
|
Societies, Medical | 1 | 2019 | 3743 | 0.020 |
Why?
|
Factor VIII | 1 | 1988 | 347 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 1997 | 4328 | 0.020 |
Why?
|
Molecular Weight | 1 | 1988 | 2255 | 0.020 |
Why?
|
Blotting, Southern | 1 | 2007 | 803 | 0.020 |
Why?
|
Carcinoma, Transitional Cell | 1 | 1993 | 808 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2018 | 19905 | 0.020 |
Why?
|
Mutant Chimeric Proteins | 1 | 2005 | 22 | 0.020 |
Why?
|
Child | 4 | 2024 | 77709 | 0.020 |
Why?
|
Lens, Crystalline | 1 | 1987 | 388 | 0.020 |
Why?
|
Up-Regulation | 2 | 2007 | 4217 | 0.020 |
Why?
|
Calcium Channels, L-Type | 1 | 2007 | 240 | 0.020 |
Why?
|
Immunoassay | 1 | 1988 | 752 | 0.020 |
Why?
|
Brain Neoplasms | 2 | 2004 | 8863 | 0.020 |
Why?
|
Boston | 1 | 2018 | 9313 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 2 | 2007 | 4554 | 0.020 |
Why?
|
Ureter | 1 | 2007 | 375 | 0.020 |
Why?
|
Prospective Studies | 3 | 2023 | 53288 | 0.020 |
Why?
|
Piperidines | 1 | 2012 | 1602 | 0.010 |
Why?
|
Models, Molecular | 1 | 2014 | 5456 | 0.010 |
Why?
|
Meningeal Neoplasms | 1 | 1993 | 1241 | 0.010 |
Why?
|
Ultrasonography, Prenatal | 1 | 1992 | 1695 | 0.010 |
Why?
|
Reoperation | 1 | 2013 | 4201 | 0.010 |
Why?
|
Chromosome Fragility | 1 | 2003 | 16 | 0.010 |
Why?
|
Chromosome Fragile Sites | 1 | 2003 | 27 | 0.010 |
Why?
|
Genes, Overlapping | 1 | 2003 | 36 | 0.010 |
Why?
|
Face | 2 | 2004 | 994 | 0.010 |
Why?
|
Euchromatin | 1 | 2003 | 56 | 0.010 |
Why?
|
Lymphocytes | 1 | 2011 | 2617 | 0.010 |
Why?
|
Pseudogenes | 1 | 2003 | 113 | 0.010 |
Why?
|
DNA Methylation | 1 | 1997 | 4286 | 0.010 |
Why?
|
Maternal Age | 1 | 2006 | 802 | 0.010 |
Why?
|
Clitoris | 1 | 2002 | 33 | 0.010 |
Why?
|
Expressed Sequence Tags | 1 | 2003 | 255 | 0.010 |
Why?
|
Aneuploidy | 1 | 2006 | 530 | 0.010 |
Why?
|
Cholesterol | 1 | 2011 | 2917 | 0.010 |
Why?
|
Retroelements | 1 | 2003 | 164 | 0.010 |
Why?
|
Gene Duplication | 1 | 2003 | 329 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2011 | 6622 | 0.010 |
Why?
|
Body Temperature Regulation | 1 | 2003 | 252 | 0.010 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2002 | 110 | 0.010 |
Why?
|
Radiation Hybrid Mapping | 1 | 2001 | 19 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7279 | 0.010 |
Why?
|
Sequence Tagged Sites | 1 | 2001 | 94 | 0.010 |
Why?
|
Genomic Imprinting | 1 | 2003 | 328 | 0.010 |
Why?
|
Chromosomes, Artificial, Bacterial | 1 | 2001 | 126 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2007 | 1701 | 0.010 |
Why?
|
Hysteroscopy | 1 | 2002 | 102 | 0.010 |
Why?
|
Williams Syndrome | 1 | 2003 | 187 | 0.010 |
Why?
|
Cytoskeletal Proteins | 1 | 2007 | 1364 | 0.010 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2003 | 431 | 0.010 |
Why?
|
Zebrafish | 1 | 2012 | 2994 | 0.010 |
Why?
|
Carcinoma, Large Cell | 1 | 2001 | 113 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2017 | 9274 | 0.010 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2002 | 294 | 0.010 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1993 | 2245 | 0.010 |
Why?
|
Gonads | 1 | 2000 | 109 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 3 | 2003 | 35421 | 0.010 |
Why?
|
Chromosomes, Human, 6-12 and X | 1 | 2000 | 80 | 0.010 |
Why?
|
Physical Chromosome Mapping | 1 | 2000 | 183 | 0.010 |
Why?
|
Collagen | 1 | 1988 | 2689 | 0.010 |
Why?
|
Metaplasia | 1 | 2001 | 313 | 0.010 |
Why?
|
Microfilament Proteins | 1 | 2005 | 1152 | 0.010 |
Why?
|
Anal Canal | 1 | 2002 | 376 | 0.010 |
Why?
|
Growth Disorders | 1 | 2004 | 645 | 0.010 |
Why?
|
Pedigree | 1 | 2007 | 4644 | 0.010 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2000 | 403 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2015 | 10481 | 0.010 |
Why?
|
Hybrid Cells | 1 | 1998 | 441 | 0.010 |
Why?
|
CpG Islands | 1 | 2003 | 1172 | 0.010 |
Why?
|
Spinal Cord | 1 | 2007 | 1809 | 0.010 |
Why?
|
Analgesia | 1 | 2003 | 461 | 0.010 |
Why?
|
Parity | 1 | 2002 | 929 | 0.010 |
Why?
|
Laparoscopy | 1 | 2010 | 2151 | 0.010 |
Why?
|
Genetic Diseases, Inborn | 1 | 2003 | 587 | 0.010 |
Why?
|
Estrogen Receptor beta | 1 | 1998 | 175 | 0.010 |
Why?
|
Birth Weight | 1 | 2006 | 2069 | 0.010 |
Why?
|
DNA Probes | 1 | 1998 | 560 | 0.010 |
Why?
|
Genotype | 1 | 2012 | 12951 | 0.010 |
Why?
|
DEAD-box RNA Helicases | 1 | 2000 | 375 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1999 | 1581 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 21746 | 0.010 |
Why?
|
Gestational Age | 1 | 2006 | 3493 | 0.010 |
Why?
|
Child, Preschool | 2 | 2012 | 41006 | 0.010 |
Why?
|
Benzodiazepines | 1 | 2003 | 1101 | 0.010 |
Why?
|
Cytoplasm | 1 | 2002 | 1539 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2001 | 1801 | 0.010 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2001 | 332 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2002 | 2726 | 0.010 |
Why?
|
Protein Binding | 1 | 1988 | 9386 | 0.010 |
Why?
|
Fibroblasts | 1 | 2007 | 4161 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2007 | 2916 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2003 | 1783 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2000 | 2256 | 0.010 |
Why?
|
Menstruation | 1 | 1997 | 302 | 0.010 |
Why?
|
Kidney | 2 | 2007 | 7186 | 0.010 |
Why?
|
Carcinoma, Papillary | 1 | 2001 | 783 | 0.010 |
Why?
|
Organ Specificity | 1 | 2000 | 2008 | 0.010 |
Why?
|
Algorithms | 1 | 2016 | 13881 | 0.010 |
Why?
|
Oocytes | 1 | 2000 | 1187 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2011 | 16689 | 0.010 |
Why?
|
Equipment Design | 1 | 2003 | 3582 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2003 | 3616 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2000 | 4320 | 0.010 |
Why?
|
Schizophrenia | 1 | 2012 | 6882 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 2282 | 0.010 |
Why?
|
United States | 1 | 2021 | 69872 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2003 | 5078 | 0.010 |
Why?
|
Postmenopause | 1 | 2002 | 2461 | 0.010 |
Why?
|
Thrombosis | 1 | 2006 | 2968 | 0.010 |
Why?
|
Amniocentesis | 1 | 1992 | 116 | 0.010 |
Why?
|
Electroencephalography | 1 | 2007 | 6150 | 0.010 |
Why?
|
Antigens, CD | 1 | 2002 | 4026 | 0.010 |
Why?
|
Reference Values | 1 | 1997 | 4982 | 0.010 |
Why?
|
Neural Tube Defects | 1 | 1992 | 256 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13695 | 0.010 |
Why?
|
Neoplasms, Multiple Primary | 1 | 1993 | 604 | 0.010 |
Why?
|
Pain | 1 | 2003 | 4986 | 0.000 |
Why?
|
Macrophages | 1 | 2002 | 5655 | 0.000 |
Why?
|
Cell Membrane Permeability | 1 | 1987 | 590 | 0.000 |
Why?
|
Chick Embryo | 1 | 1987 | 982 | 0.000 |
Why?
|
Infant | 1 | 2007 | 35136 | 0.000 |
Why?
|
Smoking | 1 | 2002 | 8987 | 0.000 |
Why?
|
Body Mass Index | 1 | 2002 | 12720 | 0.000 |
Why?
|
Microscopy, Electron | 1 | 1987 | 2645 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 2007 | 13102 | 0.000 |
Why?
|
Kinetics | 1 | 1987 | 6473 | 0.000 |
Why?
|
Heart Defects, Congenital | 1 | 1992 | 4584 | 0.000 |
Why?
|
Neoplasms | 1 | 2003 | 21683 | 0.000 |
Why?
|
Lung | 1 | 1992 | 9856 | 0.000 |
Why?
|